biotechnology company
Issues related to health care, the Food and Drug Administration (FDA), 340B Program, influenza, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, education around COVID-19 therapies, and PDUFA Reauthorization. Implementation of Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (P.L.116-22). S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; S.3799, PREVENT Pandemics Act. Issues related to appropriations and federal health programs; reimbursement and vial size issues; H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; FY2022 Consolidated Appropriations Act (H.R.2471, P.L.117-103); FY2023 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Reconciliation (H.R.5376); S.2428, False Claims Amendments Act of 2021. Implementation of Tax Cuts and Jobs Act (P.L.115-97). S.749, American Innovation and Jobs Act. Tax issues related to the Budget Reconciliation Process (H.R.5376). Biopharmaceutical innovation and patent policy issues. Trademark legislative proposals. Bayh-Dole march-in rights policy issues. Issues related to pharmaceutical IP and supply chain; S.1260, United States Innovation and Competition Act of 2021; H.R.4521, America COMPETES Act of 2022.
HCR - Health Issues BUD - Budget/Appropriations MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark TRD - Trade (domestic/foreign)
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD TODD MATTHEW WEISS JASON BENJAMIN VAN PELT JASON GLEASON SHAY MICHAEL HANCOCK MATHEW LAPINSKI TODD MATTHEW WEISS JOHN GREEN STEWART HALL HUNTER MOORHEAD JASON GLEASON SHAY MICHAEL HANCOCK JASON BENJAMIN VAN PELT TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD JASON GLEASON SHAY MICHAEL HANCOCK JASON BENJAMIN VAN PELT MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD TODD MATTHEW WEISS JASON BENJAMIN VAN PELT JASON GLEASON SHAY MICHAEL HANCOCK MATHEW LAPINSKI JOHN GREEN TODD MATTHEW WEISS STEWART HALL HUNTER MOORHEAD JASON BENJAMIN VAN PELT JASON GLEASON SHAY MICHAEL HANCOCK TODD MATTHEW WEISS MATHEW LAPINSKI JOHN GREEN STEWART HALL HUNTER MOORHEAD JASON BENJAMIN VAN PELT JASON GLEASON SHAY MICHAEL HANCOCK